These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2524769)

  • 1. [Retroperitoneal fibrosis after treatment with bromocriptine].
    Vermersch P; Foissac-Gegoux P; Caron J; Petit H
    Presse Med; 1989 Apr; 18(16):841. PubMed ID: 2524769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Retroperitoneal fibrosis after treatment by bromocriptine].
    Kaminsky P; Hirsch E; Kiesman M; Beurrier D
    Presse Med; 1989 Apr; 18(15):777. PubMed ID: 2524057
    [No Abstract]   [Full Text] [Related]  

  • 3. Retroperitoneal fibrosis and treatment of Parkinson's disease with high doses of bromocriptine.
    Demonet JF; Rostin M; Dueymes JM; Ioualalen A; Montastruc JL; Rascol A
    Clin Neuropharmacol; 1986; 9(2):200-1. PubMed ID: 3708605
    [No Abstract]   [Full Text] [Related]  

  • 4. Retroperitoneal fibrosis and bromocriptine.
    Bowler JV; Ormerod IE; Legg NJ
    Lancet; 1986 Aug; 2(8504):466. PubMed ID: 2874455
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reversible retroperitoneal fibrosis after prolonged treatment with bromocriptine: apropos of 2 cases].
    Dupuis J; Bodnar D; Sturtz F; Broussolle E; Exbrayat C; Lapras V; Chazot G
    Rev Med Interne; 1990; 11(2):183. PubMed ID: 2399383
    [No Abstract]   [Full Text] [Related]  

  • 6. Retroperitoneal fibrosis, skin and pleuropulmonary changes associated with bromocriptine therapy.
    Hely MA; Morris JG; Lawrence S; Jeremy R; Genge S
    Aust N Z J Med; 1991 Feb; 21(1):82-4. PubMed ID: 2036087
    [No Abstract]   [Full Text] [Related]  

  • 7. [Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease].
    Sánchez-Chapado M; Angulo Cuesta J; Guil Cid M; Jiménez FJ; López Alvarez YJ
    Arch Esp Urol; 1995 Dec; 48(10):979-83. PubMed ID: 8588730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroperitoneal fibrosis in two patients with Parkinson's disease treated with bromocriptine.
    Kains JP; Hardy JC; Chevalier C; Collier A
    Acta Clin Belg; 1990; 45(5):306-10. PubMed ID: 2177299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroperitoneal fibrosis in a patient treated with bromocriptine for a prolactinoma].
    Correas Gomez M; Martin Garcia B; Hernandez Rodriguez R; Portillo Martin JA; Gutierrez Banos JL; Masip TC; Fernandez Gomez JM; Asensio Lahoz LA
    J Urol (Paris); 1991; 97(4-5):234-6. PubMed ID: 1761872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.
    Ward CD; Thompson J; Humby MD
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1706-7. PubMed ID: 3437313
    [No Abstract]   [Full Text] [Related]  

  • 11. Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine.
    Herzog A; Minne H; Ziegler R
    BMJ; 1989 May; 298(6683):1315. PubMed ID: 2500220
    [No Abstract]   [Full Text] [Related]  

  • 12. [Retroperitoneal fibrosis. Apropos of 3 cases 2 of which were induced by bromocriptine].
    Hardy JC; Chevalier C; Kains JP
    Acta Urol Belg; 1991; 59(3):95-103. PubMed ID: 1759672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bromocriptine-associated retroperitoneal fibrosis presenting with testicular retraction.
    Murphy F; Pickard RS
    Br J Urol; 1989 Sep; 64(3):318-9. PubMed ID: 2804572
    [No Abstract]   [Full Text] [Related]  

  • 14. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Todman DH; Oliver WA; Edwards RL
    Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pergolide-induced retroperitoneal fibrosis.
    Mondal BK; Suri S
    Int J Clin Pract; 2000; 54(6):403. PubMed ID: 11092116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromocriptine and pleuropulmonary disease.
    Melmed S; Braunstein GD
    Arch Intern Med; 1989 Feb; 149(2):258-9. PubMed ID: 2916870
    [No Abstract]   [Full Text] [Related]  

  • 17. Retroperitoneal fibrosis caused by pergolide in a patient with Parkinson's disease.
    Bilici A; Karadag B; Doventas A; Erdincler DS; Cetinkaya S; Ogut G; Tezcan V; Beger T
    Neth J Med; 2004 Nov; 62(10):389-92. PubMed ID: 15683095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of pergolide-induced fibrosis.
    Agarwal P; Fahn S; Frucht SJ
    Mov Disord; 2004 Jun; 19(6):699-704. PubMed ID: 15197712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bromocriptine and pulmonary responses].
    Kinnunen E; Viljanen A
    Duodecim; 1989; 105(19):1614-7. PubMed ID: 2806146
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Andersohn F; Garbe E
    Mov Disord; 2009 Jan; 24(1):129-33. PubMed ID: 19170199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.